We deliver fully compliant, process-driven engineering solutions dedicated to full-scale biosimilar manufacturing plant construction, renovation and capacity expansion. Serving monoclonal antibodies, recombinant proteins, fusion proteins and other complex biologic pipelines, our engineering system strictly aligns with FDA cGMP, EMA regulatory guidelines, EU GMP and local biopharma construction standards. Built upon the Quality by Design (QbD) principle, our service integrates process similarity evaluation, contamination control and global certification adaptability into overall plant engineering, providing robust, audit-ready infrastructure for biosimilar consistency assessment and commercial mass production.
Our engineering system addresses the highly stringent technical and compliance requirements unique to biosimilar manufacturing. We implement scientific functional zoning for cell bank preservation, upstream cell culture and fermentation, downstream purification, sterile formulation and filling, and dedicated quality control laboratories. Strict hierarchical cleanroom classification from ISO 5 to ISO 8, directional pressure gradient control, and independent personnel and material flow systems effectively eliminate cross-contamination risks. Customized HVAC, purified water, process gas and waste treatment systems stabilize critical production environments to ensure consistent product purity, batch uniformity and process reproducibility.
Covering full-lifecycle project engineering, our comprehensive scope includes pre-project feasibility demonstration, process layout optimization, GMP facility design, cleanroom and structural engineering, complete MEP and utility system integration, modular construction, system commissioning and qualification validation. We tailor every engineering detail to adapt to the high-precision, low-variability production logic of biosimilar drugs, optimizing equipment placement, pipeline routing and operational workflows to reduce human interference and improve process stability. All engineering deliverables comply with global filing standards and support seamless regulatory inspection.
Backed by in-depth biosimilar industrial experience and cross-standard engineering capabilities, our solutions balance regulatory compliance, operational efficiency and long-term scalability. Our standardized engineering management minimizes scheme revision, construction rework and compliance rectification, greatly shortening project delivery and market launch cycles. Flexible spatial reserves and intelligent monitoring interfaces are embedded throughout the plant to accommodate future pipeline expansion, process optimization and digital upgrading. We help biopharma clients build cost-effective, sustainable and globally certifiable biosimilar manufacturing bases to strengthen market competitiveness in global generic biologic commercialization.
